Despite significant advancements in drug development and discovery, tuberculosis remains one of the world’s deadliest infectious diseases. The rise and global spread of multidrug-resistant strains underscore a critical need for new antibiotics with distinct mechanisms of action. Screening of a myxob...
ORGANISM(S): Escherichia coli Mycobacterium tuberculosis